文献速递临床试验与 GCP

术前CT血管成像检查对BMI≥25.0 kg/m²行腹腔镜胃切除术患者临床结局的影响:多中心随机对照试验研究方案

Effect of preoperative CT angiography examination on the clinical outcome of patients with BMI ≥ 25.0 kg/m2 undergoing laparoscopic gastrectomy: study protocol for a multicentre randomized controlled trial.
PubMed 文献 · Trials · 2021-12-11

本研究为多中心、前瞻性、开放标签随机对照试验,计划纳入382例拟行腹腔镜胃切除术的胃癌患者,按1:1随机分为CTA组(n=191)和非CTA组(n=191),两组均行上腹部增强CT,CTA组额外接受CT血管成像。主要终点为出血量,次要主要终点包括淋巴结清扫数目、术后恢复进程、住院费用、住院天数、术后并发症、3年OS和3年DFS,旨在验证CTA能否改变短期和长期临床结局。

要点

  • 拟纳入382例BMI≥25.0 kg/m²行腹腔镜胃切除术的胃癌患者,1:1随机分CTA组和非CTA组各191例。
  • 两组均行上腹部增强CT,CTA组额外接受CT血管成像。
  • 主要终点为出血量,次要主要终点包括淋巴结清扫数目、术后恢复进程、住院费用、住院天数、术后并发症、3年OS和3年DFS。

核心结论

  • 预期该试验结果将为CTA在腹腔镜胃切除术中的应用提供高级别证据并具有临床价值。

研究设计与样本

  • GISSG 20-01研究为多中心、前瞻性、开放标签临床研究,旨在验证CTA在拟行腹腔镜胃切除术患者中的临床应用。
  • 计划招募382例符合纳入标准的患者,按1:1随机分为CTA组(n=191)和非CTA组(n=191)。
  • 两组均行上腹部增强CT,CTA组额外接受CT血管成像。

关键数值与推荐

  • 主要终点为出血量。
  • 次要主要终点为淋巴结清扫数目、术后恢复进程、住院费用、住院天数、术后并发症、3年OS和3年DFS。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer, which is the fifth most common malignancy and the third most common cause of cancer-related death, is particularly predominant in East Asian countries, such as China, Japan and Korea. It is a serious global health issue that causes a heavy financial burden for the government and family. To our knowledge, there are few reports of multicentre randomized controlled trials on the utilization of CT angiography (CTA) for patients who are histologically diagnosed with gastric cancer before surgery. Therefore, we planned this RCT to verify whether the utilization of CTA can change the short- and long-term clinical outcomes. METHOD: The GISSG 20-01 study is a multicentre, prospective, open-label clinical study that emphasises the application of CTA for patients who will undergo laparoscopic gastrectomy to prove its clinical findings. A total of 382 patients who meet the inclusion criteria will be recruited for the study and randomly divided into two groups in a 1:1 ratio: the CTA group (n = 191) and the non-CTA group (n = 191). Both groups will undergo upper abdomen enhanced CT, and the CTA group will also receive CT angiography. The primary endpoint of this trial is the volume of blood loss. The second primary endpoints are the number of retrieved lymph nodes, postoperative recovery course, hospitalization costs, length of hospitalization days, postoperative complications, 3-year OS and 3-year DFS. DISCUSSION: It is anticipated that the results of this trial will provide high-level evidence and have clinical value for the application of CTA in laparoscopic gastrectomy. TRIAL REGISTRATION: ClinicalTrials.gov , NCT04636099. Registered November 19, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Meng C, Cao S, Liu X, et al. Effect of preoperative CT angiography examination on the clinical outcome of patients with BMI ≥ 25.0 kg/m2 undergoing laparoscopic gastrectomy: study protocol for a multicentre randomized controlled trial. Trials. 2021. PMID: 34895320. doi:10.1186/s13063-021-05887-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。